With the analysis among 7,425 patents, we discovered top 459 key players by total patent application. Bristol Myers Squibb Co., Boehringer Ingelheim Pharma GmbH, Novartis AG are dominant in this area. They take 9.37% of the total patent filing.
New York, United States
Patent: 301
Boehringer Ingelheim Pharma GmbH
Basel-Stadt, Switzerland
Patent: 185
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 179
New Jersey, United States
Patent: 159
New York, United States
Patent: 151
California, United States
Patent: 138
California, United States
Patent: 134
Hessen, Germany
Patent: 119
With the analysis among 148 patents, we discovered top 31 start-ups by total patent application. Biosplice Therapeutics, Inc., Autolus Ltd., Noile-Immune Biotech, Inc. are active in this area.
Biosplice Therapeutics, Inc.
California, United States
Patent: 41
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 19
Boston Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 16
Institut National de la Santé et de la Recherche Médicale
Nanjing CART Medical Technologies Co. Ltd.
Jiangsu Sheng, China
Patent: 4
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 4
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 4
California, United States
Patent: 4
With the analysis among related 1,363 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Exelixis, Inc., Bristol Myers Squibb Co., Board of Trustees of the Leland Stanford Junior University take 10.12% of patent filing during this period.
California, United States
Patent: 50
New York, United States
Patent: 47
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 41
Sumitomo Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 21
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 19
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 14
Tokyo-to, Japan
Patent: 13
Guangdong Zhaotai InVivo Biomedicine
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 13
Sumitomo Pharmaceuticals Co., Ltd.
Osaka-fu, Japan
Patent: 12
With the analysis among related 1,363 patents in last 5 years, we discover 301 new entrants. Noile-Immune Biotech, Inc., Guangdong Zhaotai InVivo Biomedicine, Guangzhou Bio-Gene Technology Co Ltd are the most active new entrants in this area.
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 19
Guangdong Zhaotai InVivo Biomedicine
Guangzhou Bio-Gene Technology Co Ltd
Guangdong Sheng, China
Patent: 10
Jiangsu Sheng, China
Patent: 9
South China Agricultural University
Guangdong Sheng, China
Patent: 8
California, United States
Patent: 8
Beijing Meikangji Free Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 8
Institut d'Investigacions Biomèdiques August Pi I Sunyer
With the analysis among 2,722 patents, we discovered top 247 universities and scientific research institutions by total patent application. New York University, The Johns Hopkins University, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 11.43% of the total patent filing.
New York, United States
Patent: 51
The Johns Hopkins University
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 38
Korea Institute of Science & Technology
Illinois, United States
Patent: 34
President & Fellows of Harvard College
Massachusetts, United States
Patent: 33
Baylor College of Medicine
Texas, United States
Patent: 30
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 29
Vlaams Instituut voor Biotechnologie - Flanders Institute
Connecticut, United States
Patent: 26